July 16 coronavirus news
4 years, 5 months ago

July 16 coronavirus news

CNN  

A pharmacy tech pours out hydroxychloroquine pills in May. George Frey/AFP/Getty Images The antimalarial drug hydroxychloroquine did not benefit non-hospitalized patients with mild symptoms from Covid-19 who were treated early in their infection, according to a study to be published Thursday in the medical journal Annals of Internal Medicine. “Taken together, there is no convincing evidence that hydroxychloroquine can either prevent COVID-19 after exposure or reduce illness severity after developing early symptoms,” study author Dr. Caleb Skipper said in a statement. “While disappointing, these results are consistent with an emerging body of literature that hydroxychloroquine doesn’t convey a substantial clinical benefit in people diagnosed with COVID-19 — despite its activity against the coronavirus in a test tube.” President Trump has called hydroxychloroquine a “game-changer” for treating patients with Covid-19, and said he took it himself to prevent infection, but several studies have found no benefits to treating Covid-19 patients with the antimalarial drug. One study published this month by researchers at Henry Ford Health System in Southeast Michigan found hydroxychloroquine increased hospitalized patients’ chances of survival.

Patients Symptoms Drug Study Hydroxychloroquine  16  patients  trial  study  coronavirus  drug  took  symptoms  covid19  placebo  prevent  hydroxychloroquine

History of this topic

"Hundreds" of Dutch died from hydroxychloroquine side effects during Covid pandemic
11 months, 2 weeks ago

"Hundreds" of Dutch died from hydroxychloroquine side effects during Covid pandemic

NL Times  

In the early phase of the coronavirus pandemic, several hundred Dutch people died from the side effects of hydroxychloroquine, the malaria drug that seemed promising against COVID-19. And laboratory research showed that this drug might work.” Of the COVID-19 patients treated in Dutch hospitals, an estimated 10,000 or so were given hydroxychloroquine, and about 2,000 ultimately died, Bonten said. “If …

Posts mislead on Mayo Clinic’s hydroxychloroquine webpage
54 years, 11 months ago

Posts mislead on Mayo Clinic’s hydroxychloroquine webpage

Associated Press  

CLAIM: The Mayo Clinic “quietly” updated its website in 2023 to say that hydroxychloroquine can now be used to treat COVID-19. A page about hydroxychloroquine on the hospital system’s website included outdated guidance that the malaria drug “may also be used to treat coronavirus in certain hospitalized patients.” But archives show the text has been there since at least May …

COVID treatments weren’t suppressed to OK vaccines’ emergency use
54 years, 11 months ago

COVID treatments weren’t suppressed to OK vaccines’ emergency use

Associated Press  

CLAIM: Ivermectin and hydroxychloroquine were suppressed as COVID-19 treatments because the vaccines couldn’t receive emergency use authorization if such treatments were available. THE FACTS: Social media users are sharing a conspiracy theory that posits that the drugs hydroxychloroquine and ivermectin were withheld as COVID-19 treatments by officials in order to greenlight vaccines under emergency use authorization. An emergency use authorization, …

Panel: Trump staffers pushed unproven COVID treatment at FDA
2 years, 4 months ago

Panel: Trump staffers pushed unproven COVID treatment at FDA

Associated Press  

WASHINGTON — Officials in the Trump White House tried to pressure U.S. health experts into reauthorizing a discredited COVID-19 treatment, according to a congressional investigation that provides new evidence of that administration’s efforts to override Food and Drug Administration decisions early in the pandemic. But Hahn told investigators that he felt pressure due to the “persistence” of Trump aide Peter …

Merck’s COVID pill shows lower efficacy in updated study
3 years ago

Merck’s COVID pill shows lower efficacy in updated study

Al Jazeera  

Drugmaker says final analysis of trial results showed molnupiravir led to 30 percent reduction in hospitalisations and deaths, compared with about 50 percent in interim study. Drugmaker Merck’s experimental COVID-19 pill is significantly less effective in slashing hospitalisations and deaths than previously reported, the company has said, following the release of a full analysis of trial results. The United States-based …

Remember Donald Trump-touted hydroxychloroquine? Study in India backs it as Covid-19 cure
3 years, 6 months ago

Remember Donald Trump-touted hydroxychloroquine? Study in India backs it as Covid-19 cure

India Today  

Hydroxychloroquine, the malaria drug touted as a magical Covid-19 cure by former US President Donald Trump last year, has been found effective in a prophylactic study published in the Journal of The Association of Physicians of India last week. The study said, “hen adjusted for other risk factors, HCQ dose as per government recommendations, 2-3, 4-5, 6 or more weeks …

Hydroxychloroquine shouldn’t be used as Covid preventive, says WHO
3 years, 9 months ago

Hydroxychloroquine shouldn’t be used as Covid preventive, says WHO

Hindustan Times  

Anti-inflammatory drug hydroxychloroquine should not be used in efforts to prevent infection with Covid-19, according to the World Health Organization. Hydroxychloroquine was touted as a Covid-19 treatment by former President Donald Trump and later deemed ineffective. The WHO’s recommendation is based on evidence from six randomized controlled trials with more than 6,000 participants with or without known exposure to a …

ICMR may remove plasma therapy from Covid-19 treatment guidelines
4 years, 2 months ago

ICMR may remove plasma therapy from Covid-19 treatment guidelines

Live Mint  

New Delhi: The government is planning to delete convalescent plasma therapy from the national guidelines for covid-19 treatment after the Indian Council of Medical Research’s clinical trial showed that the therapy did not significantly benefit patients suffering from the disease, ICMR DG Balram Bhargava said on Tuesday. ICMR, which is the government’s apex bio-medical research agency, had conducted a 464 …

WHO trial finds remdesivir has little effect on COVID-19
4 years, 2 months ago

WHO trial finds remdesivir has little effect on COVID-19

Al Jazeera  

Early results from large, randomised trial suggest antiviral does little to reduce mortality rates or time in hospital. A World Health Organization trial using four drugs including the antiviral remdesivir in the hospital treatment of COVID-19 has found the repurposed medicines have little to no effect on the length of time patients spend in hospital or their survival. “These Remdesivir, …

Hydroxycloroquine does not help with Covid mortality; Improves ICU risk
4 years, 2 months ago

Hydroxycloroquine does not help with Covid mortality; Improves ICU risk

NL Times  

Hydroxychloroquine, a malaria drug often used to treat Covid-19, does not have a noticeable effect on the mortality rate of the coronavirus, according to a study by 14 Dutch hospitals. The hospitals analyzed 1,064 Covid-19 patients in 14 hospitals, 189 of whom were treated with hydroxychloroquine, 377 were treated with chloroquine, and 498 were not treated with either of the …

Anti-malaria drug hydroxychloroquine ineffective against coronavirus, reveal UK RECOVERY Trials
4 years, 2 months ago

Anti-malaria drug hydroxychloroquine ineffective against coronavirus, reveal UK RECOVERY Trials

Firstpost  

The results of the study, published by NEJM, showed that COVID-19 patients who did not need mechanical ventilation to begin with had a higher likelihood of needing ventilation or dying when they were put on hydroxychloroquine Hydroxychloroquine is no better than usual care in reducing the chances of death in COVID-19 patients, suggest the results of RECOVERY Trials published Thursday …

Re-purposed Hydroxychloroquine Being Used for Mild, Moderate Covid-19 Cases: Harsh Vardhan
4 years, 3 months ago

Re-purposed Hydroxychloroquine Being Used for Mild, Moderate Covid-19 Cases: Harsh Vardhan

News 18  

Re-purposed hydroxychloroquine is being used for mild but high risk and moderate COVID-19 cases, Union Health Minister Harsh Vardhan said in Rajya Sabha on Tuesday. “One prophylactic trial of Aswagandha and three trials of Guduchi + Pippali; Yashtimadhu; and polyherbal AYUSH drug are planned on moderately ill Covid19 patients,” he said. Government action of nationwide lockdown, community involvement etc has …

Amsterdam study shows hydroxychloroquine ineffective in Covid-19 treatment
4 years, 4 months ago

Amsterdam study shows hydroxychloroquine ineffective in Covid-19 treatment

NL Times  

Hydroxychloroquine was not effective in treating Covid-19 in Dutch hospitals during the coronavirus crisis, according to a study by Amsterdam scientists led by internist-infectiologist Edgar Peters of Amsterdam UMC. The Amsterdam researchers compared seven hospitals where Hydroxychloroquine was included in the treatment guideline in the early months of the crisis, to two hospitals where the drug was not prescribed. In …

Everything you wanted to know about covid-19 treatments, in five charts
4 years, 4 months ago

Everything you wanted to know about covid-19 treatments, in five charts

Live Mint  

When India’s National Task Force on COVID-19 recommended against including Itolizumab, Biocon’s psoriasis drug, in its treatment guidelines, the move represented two key aspects of the global scramble for a cure for covid-19 - the problematic bar for evidence, as well as the sheer size of the challenge. Perhaps no drug candidate in the race for a cure for covid-19 …

Where are we in finding a treatment for COVID-19?
4 years, 4 months ago

Where are we in finding a treatment for COVID-19?

Al Jazeera  

Some drugs and treatments have shown promise in clinical trials, while others are drawing controversy. More information on the efficacy of remdesivir in patients with COVID-19 is expected from large clinical trials such as the WHO-coordinated Solidarity Trial and the Recovery Trial in the United Kingdom. “It’s really important that these drugs be evaluated in robust clinical trials before being …

Hydroxychloroquine is a poor coronavirus treatment but a perfect parable for our times
4 years, 4 months ago

Hydroxychloroquine is a poor coronavirus treatment but a perfect parable for our times

ABC  

The group had all the trappings of medical authority. Since March 1, public posts containing the word "hydroxychloroquine" have received at least 55 million "interactions" on Facebook — a measure that includes reactions, shares or comments. And in the months since, President Trump and members of his administration have repeatedly returned to the hydroxychloroquine narrative despite the protests of White …

Hydroxychloroquine: Researchers publish scathing critique of Henry Ford study touted by the White House
4 years, 4 months ago

Hydroxychloroquine: Researchers publish scathing critique of Henry Ford study touted by the White House

CNN  

CNN — Researchers on Wednesday published scathing critiques of a study President Trump repeatedly touted on Twitter. “The highly respected Henry Ford Health System just reported, based on a large sampling, that HYDROXYCHLOROQUINE cut the death rate in certain sick patients very significantly. For example, the patients in the Henry Ford study who were given hydroxychloroquine had fewer risk factors …

Trump Defends Use of Hydroxychloroquine, Says It Works in Early Stages of Covid-19 Infection
4 years, 4 months ago

Trump Defends Use of Hydroxychloroquine, Says It Works in Early Stages of Covid-19 Infection

News 18  

US President Donald Trump has again defended the use of hydroxychloroquine to ward off coronavirus, saying many frontline medical workers agree with him that the malaria drug works in the early stages of COVID-19 infection, despite mounting evidence that it is ineffective in treating the disease. I think frontline medical people believe that too — some, many," Trump told reporters …

Brazil’s cult of hydroxychloroquine
4 years, 4 months ago

Brazil’s cult of hydroxychloroquine

CNN  

Brasilia, Brazil CNN — The police cavalry horses pranced through red dust towards an open grave nobody expected would be dug for Sgt. Jo Shelley for CNN In Brazil – home to South America’s worst coronavirus outbreak, where as many as 50,000 new cases have been recorded per day – the drug is at the heart of a febrile scrap …

Video falsely touts hydroxychloroquine as COVID-19 cure
4 years, 4 months ago

Video falsely touts hydroxychloroquine as COVID-19 cure

Associated Press  

CLAIM: A video makes numerous claims about preventing the coronavirus, stating that hydroxychloroquine can prevent and cure COVID-19, and wearing masks and keeping people locked down have no value. “There is no evidence done in a rigorous study that shows hydroxychloroquine in combination with azithromycin or zinc or whatever combination you use that has any benefit in the treatment of …

Hydroxychloroquine doesn’t work in non-hospitalized patients
4 years, 5 months ago

Hydroxychloroquine doesn’t work in non-hospitalized patients

CNN  

CNN — The antimalarial drug hydroxychloroquine did not benefit non-hospitalized patients with mild Covid-19 symptoms who were treated early in their infection, according to a study published Thursday in the medical journal Annals of Internal Medicine. “Taken together, there is no convincing evidence that hydroxychloroquine can either prevent COVID-19 after exposure or reduce illness severity after developing early symptoms,” study …

No room for complacency, says PM Modi after COVID-19 review
4 years, 5 months ago

No room for complacency, says PM Modi after COVID-19 review

The Hindu  

Prime Minister Narendra Modi on Saturday, following a COVID-19 review meeting with Home Minister Amit Shah, Health Minister Harsh Vardhan and other senior government officials, reiterated the need to observe personal hygiene and social discipline in public places while appreciating the manner in which the pandemic has been “contained” in Delhi. “There are 2,83,407 active cases and all are under …

Gilead says remdesivir reduced risk of death in coronavirus patients, more studies needed
4 years, 5 months ago

Gilead says remdesivir reduced risk of death in coronavirus patients, more studies needed

India Today  

Gilead Sciences Inc said on Friday additional data from a late-stage study showed its antiviral remdesivir reduced the risk of death and significantly improved the conditions of severely ill COVID-19 patients. Gilead said it analyzed data from 312 patients treated in a late-stage study and a separate real-world retrospective cohort of 818 patients with similar characteristics and disease severity as …

Trump's Claim That Hydroxychloroquine 'Doesn't Kill People' Looks Worse And Worse
4 years, 5 months ago

Trump's Claim That Hydroxychloroquine 'Doesn't Kill People' Looks Worse And Worse

Huff Post  

In late May, Trump also said he had taken hydroxychloroquine for two weeks as a preventative against the coronavirus, even though studies have found that hydroxychloroquine has either no benefit or poses an even greater risk of death. In late March, the Food and Drug Administration issued an emergency authorization for hydroxychloroquine usage with COVID-19 patients, although it admitted, “We …

Coronavirus: Hydroxychloroquine trialled over better treatments
4 years, 5 months ago

Coronavirus: Hydroxychloroquine trialled over better treatments

Daily Mail  

More than 1,200 studies looking at treatment and prevention of coronavirus are often too small to provide conclusive results and are focusing too much on one potential therapy, a new analysis reveals. Commissioned by STAT News, the report found that one in every six clinical trials studied the anti-malaria drugs hydroxychloroquine or chloroquine despite thin evidence that either are effective …

US prescriptions for hydroxychloroquine skyrocketed from February to March, study finds
4 years, 5 months ago

US prescriptions for hydroxychloroquine skyrocketed from February to March, study finds

CNN  

CNN — Prescriptions for the anti-malarial drugs chloroquine and hydroxychloroquine skyrocketed in the US from February to March, a time when the drugs, though unproven, were touted as treatments for the coronavirus. Researchers found the estimated number of hydroxychloroquine prescriptions increased 86.2% from February to March, from 367,346 to 683,999, and dispensed chloroquine prescriptions increased 158.6%, rising from 2,346 to …

WHO COVID-19 Trial drops hydroxychloroquine, HIV combo lopinavir/ritonavir after 'lack of evidence' in hospitalised patients
4 years, 5 months ago

WHO COVID-19 Trial drops hydroxychloroquine, HIV combo lopinavir/ritonavir after 'lack of evidence' in hospitalised patients

Firstpost  

Hydroxychloroquine and lopinavir/ritonavir produced little or no reduction in the mortality in hospitalized patients compared to standard of care, the trial concluded. The World Health Organisation has pulled the steroid drug hydroxychloroquine and HIV treatment combination lopinavir/ritonavir from their ongoing COVID-19 Solidarity trials, after a recommendation from the international Steering Committee advising the same. The Committee’s recommendation comes after mounting …

WHO ending hydroxychloroquine trial for COVID
4 years, 5 months ago

WHO ending hydroxychloroquine trial for COVID

LA Times  

The World Health Organization says it is ending a trial into whether the anti-malaria drug hydroxychloroquine helps patients hospitalized with COVID-19. The WHO said Saturday it has “accepted the recommendation” from the committee overseeing the trial to discontinue testing of hydroxychloroquine and lopinavir/ritonavir, a drug combination used to treat HIV/AIDS. The United Nations agency says a review of the interim …

Study finds hydroxychloroquine helped coronavirus patients survive better
4 years, 5 months ago

Study finds hydroxychloroquine helped coronavirus patients survive better

CNN  

CNN — A surprising new study found the controversial antimalarial drug hydroxychloroquine helped patients better survive in the hospital. A team at Henry Ford Health System in southeast Michigan said Thursday their study of 2,541 hospitalized patients found that those given hydroxychloroquine were much less likely to die. The US Food and Drug Administration withdrew its emergency use authorization for …

Hydroxychloroquine: NIH halts clinical trial after finding no additional benefit for Covid-19 patients
4 years, 6 months ago

Hydroxychloroquine: NIH halts clinical trial after finding no additional benefit for Covid-19 patients

CNN  

CNN — The National Institutes of Health announced Saturday that it has halted a clinical trial evaluating the safety and effectiveness of drug hydroxychloroquine as a treatment for adults hospitalized with Covid-19. “A data and safety monitoring board met late Friday and determined that while there was no harm, the study drug was very unlikely to be beneficial to hospitalized …

NIH Halts Hydroxychloroquine Study; Says 'Unlikely' To Help COVID-19 Patients
4 years, 6 months ago

NIH Halts Hydroxychloroquine Study; Says 'Unlikely' To Help COVID-19 Patients

NPR  

NIH Halts Hydroxychloroquine Study; Says 'Unlikely' To Help COVID-19 Patients Enlarge this image toggle caption Lev Radin/Pacific Press/Pacific Press/LightRocket via Ge Lev Radin/Pacific Press/Pacific Press/LightRocket via Ge The National Institutes of Health has halted its study of hydroxychloroquine, a drug President Donald Trump has promoted as a possible treatment for COVID-19 and once claimed to be taking himself. In a …

Hydroxychloroquine: US stockpile stuck with 63 million doses of the drug
4 years, 6 months ago

Hydroxychloroquine: US stockpile stuck with 63 million doses of the drug

CNN  

CNN — The federal government is stuck with 63 million doses of hydroxychloroquine now that the US Food and Drug Administration has revoked permission for the drug to be distributed to treat coronavirus patients. The government started stockpiling donated hydroxychloroquine in late March, after President Trump touted it as “very encouraging” and “very powerful” and a “game-changer.” But Monday, the …

Indian doctors express cautious endorsement for dexamethasone for COVID-19
4 years, 6 months ago

Indian doctors express cautious endorsement for dexamethasone for COVID-19

The Hindu  

Indian doctors have said the reported success of dexamethasone — an inexpensive steroid that retails for less than ₹10 for 10 ml and is made by several Indian manufacturers — at curing COVID-19 patients on ventilators is good news for India. Scientists administering the WHO-administered RECOVERY trial — the largest global clinical trial — that is checking the ability of …

Coronavirus | Dexamethasone reduces deaths from COVID-19, say researchers in U.K.
4 years, 6 months ago

Coronavirus | Dexamethasone reduces deaths from COVID-19, say researchers in U.K.

The Hindu  

Researchers in the U.K. say they have the first evidence that a drug can improve COVID-19 survival: A steroid called dexamethasone reduced deaths by up to one third in severely ill hospitalised patients. The study is a large, strict test that randomly assigned 2,104 patients to get the drug and compared them with 4,321 patients getting only usual care. “The …

Hydroxychloroquine: Brazil recommends unproven drug for pregnant women and children despite FDA ban
4 years, 6 months ago

Hydroxychloroquine: Brazil recommends unproven drug for pregnant women and children despite FDA ban

CNN  

Sao Paulo CNN — Brazilian health authorities said on Monday they will now recommend hydroxychloroquine to treat children and pregnant women for early treatment of Covid-19, and criticized the US Food and Drug Administration’s recent decision to revoke the emergency use of the drug. “The studies referenced by the FDA today cannot be used as examples for Brazil or for …

Steroid drug: A ‘breakthrough’ in the fight against coronavirus?
4 years, 6 months ago

Steroid drug: A ‘breakthrough’ in the fight against coronavirus?

Al Jazeera  

UK has approved the drug use in the state-run health service and stockpiled 200,000 courses of the treatment. A cheap and widely-used steroid called dexamethasone has become the first drug shown to be able to save lives among COVID-19 patients in what scientists said is a “major breakthrough” in the coronavirus pandemic. “This is a result that shows that if …

FDA revokes emergency use authorisation for hydroxychloroquine
4 years, 6 months ago

FDA revokes emergency use authorisation for hydroxychloroquine

The Hindu  

On June 15, the U.S. Food and Drug Administration revoked the emergency use authorization issued for two drugs — hydroxychloroquine sulfate and chloroquine phosphate — for use in certain hospitalised COVID-19 patients. The FDA further added: “In light of ongoing serious cardiac adverse events and other serious side effects, the known and potential benefits of CQ and HCQ no longer …

FDA Withdraws Emergency Use Authorization For Hydroxychloroquine
4 years, 6 months ago

FDA Withdraws Emergency Use Authorization For Hydroxychloroquine

NPR  

FDA Withdraws Emergency Use Authorization For Hydroxychloroquine toggle caption David J. Phillip/AP The U.S. Food and Drug Administration today withdrew a special status known as emergency use authorization for the drugs chloroquine and hydroxychloroquine. Emergency use authorization is designed to facilitate the availability of drugs needed during public health emergencies. The FDA granted the emergency use authorization in March. "It …

Hydroxychloroquine: FDA revokes authorization of drug Trump touted
4 years, 6 months ago

Hydroxychloroquine: FDA revokes authorization of drug Trump touted

CNN  

CNN — The Food and Drug Administration has revoked its emergency use authorization for the drugs hydroxychloroquine and chloroquine for the treatment of Covid-19. After reviewing the current research available on the drugs, the FDA determined that the drugs do not meet “the statutory criteria” for emergency use authorization as they are unlikely to be effective in treating Covid-19 based …

Hydroxychloroquine does not reduce mortality, RECOVERY trial finds
4 years, 6 months ago

Hydroxychloroquine does not reduce mortality, RECOVERY trial finds

The Hindu  

The RECOVERY trial, a large randomised controlled trial in the U.K. to test five drugs, including hydroxychloroquine, has found no clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19. We have therefore decided to stop enrolling participants to the hydroxychloroquine arm of the RECOVERY Trial with immediate effect,” a June 5 press release says. The RECOVERY trial has …

Coronavirus | Avoid hydroxychloroquine in COVID-19 patients with severe disease, says Health Ministry protocol
4 years, 6 months ago

Coronavirus | Avoid hydroxychloroquine in COVID-19 patients with severe disease, says Health Ministry protocol

The Hindu  

The Health Ministry on Saturday said the anti-malarial drug hydroxychloroquine should be used as early as possible in the course of coronavirus treatment to achieve any meaningful effects and should be avoided in patients with severe disease. Hydroxychloroquine clinical trials will resume, says WHO A 22-page new, national clinical management protocol provides for the management of COVID-19 cases based on …

Health Ministry okays HCQ for early course of Covid-19, remdesivir under emergency use
4 years, 6 months ago

Health Ministry okays HCQ for early course of Covid-19, remdesivir under emergency use

India Today  

The Union Health Ministry has recommended the use of anti-viral drug remdesivir under emergency use authorization, off-label application of immunomodulator tocilizumab and convalescent plasma therapy for treating Covid-19 patients in moderate stage of criticality. Backtracking from its earlier stance, the ministry said anti-malarial drug hydroxychloroquine should be used in the early course of the disease to achieve any meaningful effect …

Govt reviews use of HCQ and antibiotic combo in treating coronavirus cases
4 years, 6 months ago

Govt reviews use of HCQ and antibiotic combo in treating coronavirus cases

Hindustan Times  

The Union health ministry is reviewing use of anti-malarial drug hydroxychloroquine, in combination with antibiotic azithromycin, for treating coronavirus disease on patients in India, and is likely to come up with revised clinical management guidelines for this soon. The drug hydroxychloroquine, pushed by US President Donald Trump and others in recent months as a possible treatment to people infected with …

The jury is still out on Hydroxychloroquine after the global debacle have left scientists uncertain of its usage
4 years, 6 months ago

The jury is still out on Hydroxychloroquine after the global debacle have left scientists uncertain of its usage

Firstpost  

The WHO paused its trials when The Lancet study showed the drug was tied to an increased risk of death in hospitalized patients. Scientists are resuming COVID-19 trials of the now world-famous drug hydroxychloroquine, as confusion continues to reign about the anti-malarial hailed by U.S. President Donald Trump as a potential “game-changer” in fighting the pandemic. The World Health Organization, …

UK halts hydroxychloroquine trial after experts find no reduction in risk of death among coronavirus patients
4 years, 6 months ago

UK halts hydroxychloroquine trial after experts find no reduction in risk of death among coronavirus patients

Firstpost  

British scientists halted a major drug trial after it found that the anti-malarial hydroxychloroquine was ‘useless’ at treating COVID-19 patients London: British scientists halted a major drug trial on Friday after it found that the anti-malarial hydroxychloroquine, touted by US President Donald Trump as a potential “game changer” in the pandemic, was “useless” at treating COVID-19 patients. We can now …

Authors retract Lancet study that claimed higher death risk for COVID-19 patients treated with hydroxychloroquine
4 years, 6 months ago

Authors retract Lancet study that claimed higher death risk for COVID-19 patients treated with hydroxychloroquine

Firstpost  

An influential medical journal article that found hydroxychloroquine increased the risk of death in COVID-19 patients was retracted on Thursday, adding to controversy around a drug championed by US President Donald Trump. The three authors said Surgisphere, the company that provided the data, would not transfer the dataset for an independent review and they “can no longer vouch for the …

Coronavirus | Authors pull controversial Lancet study flagging hydroxychloroquine risks
4 years, 6 months ago

Coronavirus | Authors pull controversial Lancet study flagging hydroxychloroquine risks

The Hindu  

The Lancet on Thursday retracted a study that raised safety fears over the use of a drug favoured by President Donald Trump to treat COVID-19, after the paper's authors said they could no longer vouch for its underlying data. It was soon followed by the withdrawal of another coronavirus paper in the New England Journal of Medicine that was not …

UK Covid-19 trial ends hydroxychloroquine study because there’s no evidence the drug benefits patients
4 years, 6 months ago

UK Covid-19 trial ends hydroxychloroquine study because there’s no evidence the drug benefits patients

CNN  

CNN — Researchers in the United Kingdom have put an abrupt stop to an arm of their Covid-19 trial that involves the antimalarial drug hydroxychloroquine. The Recovery trial, a large UK-based trial investigating potential coronavirus treatments, has stopped including hydroxychloroquine in its study due to there being “no evidence of benefit,” researchers announced on Friday. “We reviewed the data and …

WHO will resume its trial of hydroxychloroquine after studies claiming increased death rates are called into question
4 years, 6 months ago

WHO will resume its trial of hydroxychloroquine after studies claiming increased death rates are called into question

Firstpost  

WHO’s chief scientist said “We owe it to patients to have a definitive answer on whether or not a drug works." The U.N. agency last month paused the part of its large study of treatments against COVID-19 in which newly enrolled patients were getting the anti-malarial drug to treat COVID-19 due to fears it increased death rates and irregular heartbeats. …

Discover Related